Losses of heterozygosity on chromosomes 17p and 9p/18q my play important roles in early and advanced phases of gallbladder carcinogenesis

被引:26
作者
Hidaka, E
Yanagisawa, A
Sakai, Y
Seki, M
Kitagawa, T
Setoguchi, T
Kato, Y
机构
[1] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 1708455, Japan
[2] Canc Inst Hosp, Dept Surg, Tokyo, Japan
[3] Miyazaki Med Coll, Dept Surg 1, Miyazaki 88916, Japan
关键词
LOH; p53; overexpression; Ki-ras; gallbladder carcinoma;
D O I
10.1007/s004320050300
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This present study aimed to investigate the genetic changes in gallbladder carcinogenesis. Methods: Eleven intramucosal gallbladder carcinomas were compared with 31 invasive lesions for loss of heterozygosity (LOH) on chromosomes 5q, 9p, 17p and 18q, frame-shift mutations in a ten-adenine repeat site within the gene encoding the transforming growth factor beta type II receptor (TGF beta RII) and an eight-guanine repeat site within BAX, and point mutations in codon 12 of Ki-ras. Results: The incidences of LOH in intramucosal and invasive carcinomas were 14% and 17% on 5q, 9% and 52% on 9p, 64% and 65% on 17p, and 13% and 32% on 18q. No frame-shift mutations were found at TGF beta RII or BAX, and point mutations in codon 12 of Ki-ras were present in only 8% of the samples. Thus, LOH on 17p was by far the most frequent lesion with similar results in both intramucosal and invasive carcinomas. In contrast, the frequency of LOH on 9p and 18q was distinctly higher in invasive lesions. Conclusion: The present data suggest that LOH on 17p may play an important role in the evolution of gallbladder carcinoma from a relatively early phase, while LOH on 9p and 18q may play roles in progression.
引用
收藏
页码:439 / 443
页数:5
相关论文
共 30 条
[1]   K-ras gene mutation in gall bladder carcinomas and dysplasia [J].
Ajiki, T ;
Fujimori, T ;
Onoyama, H ;
Yamamoto, M ;
Kitazawa, S ;
Maeda, S ;
Saitoh, Y .
GUT, 1996, 38 (03) :426-429
[2]  
Albores-Saavedra J, 1991, WHO HISTOLOGICAL TYP
[3]   Long-term results after curative resection for carcinoma of the gallbladder [J].
Benoist, S ;
Panis, Y ;
Fagniez, PL .
AMERICAN JOURNAL OF SURGERY, 1998, 175 (02) :118-122
[4]  
CUNNINGHAM J, 1992, CANCER RES, V52, P1974
[5]   MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].
Eppert, K ;
Scherer, SW ;
Ozcelik, H ;
Pirone, R ;
Hoodless, P ;
Kim, H ;
Tsui, LC ;
Bapat, B ;
Gallinger, S ;
Andrulis, IL ;
Thomsen, GH ;
Wrana, JL ;
Attisano, L .
CELL, 1996, 86 (04) :543-552
[6]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[7]  
Hanada K, 1996, CANCER, V77, P452, DOI 10.1002/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO
[8]  
2-M
[9]  
Imai Y, 1998, INT J CANCER, V76, P407, DOI 10.1002/(SICI)1097-0215(19980504)76:3<407::AID-IJC19>3.0.CO
[10]  
2-7